CLLS
Income statement / Annual
Last year (2025), Cellectis's total revenue was $72.95 M,
an increase of 75.76% from the previous year.
In 2025, Cellectis's net income was -$67.59 M.
See Cellectis,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$72.95 M |
$41.51 M |
$755.00 K |
$19.17 M |
$30.35 M |
$51.06 M |
$15.19 M |
$12.73 M |
$25.19 M |
$42.58 M |
| Cost of Revenue |
$9.80 M
|
$9.18 M
|
$7.42 M
|
$8.48 M
|
$1.84 M
|
$1.95 M
|
$11.39 M
|
$2.74 M
|
$2.62 M
|
$1.69 M
|
| Gross Profit |
$63.15 M
|
$32.32 M
|
-$6.66 M
|
$10.69 M
|
$28.50 M
|
$49.11 M
|
$3.80 M
|
$9.99 M
|
$22.57 M
|
$40.90 M
|
| Gross Profit Ratio |
0.87
|
0.78
|
-8.83
|
0.56
|
0.94
|
0.96
|
0.25
|
0.78
|
0.9
|
0.96
|
| Research and Development Expenses |
$93.52 M
|
$90.54 M
|
$87.65 M
|
$97.50 M
|
$117.84 M
|
$77.05 M
|
$92.04 M
|
$76.57 M
|
$79.23 M
|
$74.56 M
|
| General & Administrative Expenses |
$8.60 M
|
$8.42 M
|
$8.12 M
|
$8.90 M
|
$37.87 M
|
$22.51 M
|
$43.02 M
|
$47.25 M
|
$44.75 M
|
$41.26 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$2.71 M
|
$0.00
|
$0.00
|
$16.69 M
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$8.60 M
|
$8.42 M
|
$8.12 M
|
$8.90 M
|
$22.88 M
|
$22.51 M
|
$43.02 M
|
$47.25 M
|
$44.75 M
|
$41.26 M
|
| Other Expenses |
-$5.89 M
|
-$7.08 M
|
-$5.13 M
|
-$6.04 M
|
-$8.74 M
|
-$8.15 M
|
-$7.71 M
|
-$25.42 M
|
-$17.90 M
|
-$19.38 M
|
| Operating Expenses |
$96.23 M
|
$91.88 M
|
$90.64 M
|
$100.35 M
|
$131.98 M
|
$91.42 M
|
$127.35 M
|
$115.08 M
|
$115.22 M
|
$104.86 M
|
| Cost And Expenses |
$106.03 M
|
$101.06 M
|
$98.06 M
|
$108.84 M
|
$133.83 M
|
$93.37 M
|
$138.74 M
|
$117.82 M
|
$117.84 M
|
$106.54 M
|
| Interest Income |
$9.50 M
|
$11.28 M
|
$3.61 M
|
$1.12 M
|
$719.00 K
|
$1.96 M
|
$6.98 M
|
$6.79 M
|
$1.97 M
|
$44.17 K
|
| Interest Expense |
$8.11 M
|
$7.45 M
|
$5.31 M
|
$3.79 M
|
$4.37 M
|
$3.65 M
|
$2.96 M
|
$723.00 K
|
$560.00 K
|
$6.31 K
|
| Depreciation & Amortization |
$20.06 M
|
$19.85 M
|
$18.52 M
|
$18.44 M
|
$14.16 M
|
$7.83 M
|
$6.88 M
|
$2.38 M
|
$3.37 M
|
$2.21 M
|
| EBITDA |
-$39.85 M |
-$9.46 M |
-$92.64 M |
-$76.38 M |
-$78.43 M |
-$43.34 M |
-$105.73 M |
-$93.79 M |
-$108.08 M |
-$65.32 M |
| EBITDA Ratio |
-0.55
|
-0.23
|
-122.7
|
-3.98
|
-2.58
|
-0.85
|
-6.96
|
-7.37
|
-4.29
|
-1.53
|
| Operating Income Ratio |
-0.45
|
-1.43
|
-128.88
|
-4.68
|
-3.41
|
-0.83
|
-8.13
|
-8.25
|
-3.68
|
-1.5
|
| Total Other Income/Expenses Net |
-$34.94 M
|
$22.79 M
|
-$19.16 M
|
-$8.94 M
|
$6.73 M
|
-$11.27 M
|
$8.34 M
|
$16.76 M
|
-$11.03 M
|
$47.00 K
|
| Income Before Tax |
-$68.02 M
|
-$36.76 M
|
-$116.46 M
|
-$98.60 M
|
-$96.75 M
|
-$53.58 M
|
-$115.21 M
|
-$88.33 M
|
-$103.68 M
|
-$63.92 M
|
| Income Before Tax Ratio |
-0.93
|
-0.89
|
-154.26
|
-5.14
|
-3.19
|
-1.05
|
-7.58
|
-6.94
|
-4.12
|
-1.5
|
| Income Tax Expense |
-$423.00 K
|
$0.00
|
$371.00 K
|
$87.00 K
|
-$3.00 K
|
$0.00
|
$0.00
|
$0.00
|
-$13.20 M
|
-$1.54 M
|
| Net Income |
-$67.59 M
|
-$36.76 M
|
-$101.06 M
|
-$106.14 M
|
-$114.20 M
|
-$81.07 M
|
-$102.09 M
|
-$78.69 M
|
-$99.37 M
|
-$63.92 M
|
| Net Income Ratio |
-0.93
|
-0.89
|
-133.85
|
-5.54
|
-3.76
|
-1.59
|
-6.72
|
-6.18
|
-3.95
|
-1.5
|
| EPS |
-0.68 |
-0.41 |
-1.77 |
-2.33 |
-1.93 |
-1.71 |
-2.14 |
-1.93 |
-2.78 |
-1.81 |
| EPS Diluted |
-0.68 |
-0.41 |
-1.77 |
-2.33 |
-1.93 |
-1.71 |
-2.14 |
-1.93 |
-2.78 |
-1.78 |
| Weighted Average Shares Out |
$100.28 M
|
$90.57 M
|
$57.01 M
|
$45.55 M
|
$44.82 M
|
$42.50 M
|
$42.44 M
|
$40.77 M
|
$35.69 M
|
$35.29 M
|
| Weighted Average Shares Out Diluted |
$100.28 M
|
$90.57 M
|
$57.01 M
|
$45.55 M
|
$44.82 M
|
$42.50 M
|
$42.44 M
|
$40.77 M
|
$35.69 M
|
$35.81 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
